Cargando…
Inflammasomes and Fibrosis
Fibrosis is the final common pathway of inflammatory diseases in various organs. The inflammasomes play an important role in the progression of fibrosis as innate immune receptors. There are four main members of the inflammasomes, such as NOD-like receptor protein 1 (NLRP1), NOD-like receptor protei...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226128/ https://www.ncbi.nlm.nih.gov/pubmed/34177893 http://dx.doi.org/10.3389/fimmu.2021.643149 |
_version_ | 1783712220292579328 |
---|---|
author | Zhang, Wen-Juan Chen, Shu-Juan Zhou, Shun-Chang Wu, Su-Zhen Wang, Hui |
author_facet | Zhang, Wen-Juan Chen, Shu-Juan Zhou, Shun-Chang Wu, Su-Zhen Wang, Hui |
author_sort | Zhang, Wen-Juan |
collection | PubMed |
description | Fibrosis is the final common pathway of inflammatory diseases in various organs. The inflammasomes play an important role in the progression of fibrosis as innate immune receptors. There are four main members of the inflammasomes, such as NOD-like receptor protein 1 (NLRP1), NOD-like receptor protein 3 (NLRP3), NOD-like receptor C4 (NLRC4), and absent in melanoma 2 (AIM2), among which NLRP3 inflammasome is the most studied. NLRP3 inflammasome is typically composed of NLRP3, ASC and pro-caspase-1. The activation of inflammasome involves both “classical” and “non-classical” pathways and the former pathway is better understood. The “classical” activation pathway of inflammasome is that the backbone protein is activated by endogenous/exogenous stimulation, leading to inflammasome assembly. After the formation of “classic” inflammasome, pro-caspase-1 could self-activate. Caspase-1 cleaves cytokine precursors into mature cytokines, which are secreted extracellularly. At present, the “non-classical” activation pathway of inflammasome has not formed a unified model for activation process. This article reviews the role of NLRP1, NLRP3, NLRC4, AIM2 inflammasome, Caspase-1, IL-1β, IL-18 and IL-33 in the fibrogenesis. |
format | Online Article Text |
id | pubmed-8226128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82261282021-06-26 Inflammasomes and Fibrosis Zhang, Wen-Juan Chen, Shu-Juan Zhou, Shun-Chang Wu, Su-Zhen Wang, Hui Front Immunol Immunology Fibrosis is the final common pathway of inflammatory diseases in various organs. The inflammasomes play an important role in the progression of fibrosis as innate immune receptors. There are four main members of the inflammasomes, such as NOD-like receptor protein 1 (NLRP1), NOD-like receptor protein 3 (NLRP3), NOD-like receptor C4 (NLRC4), and absent in melanoma 2 (AIM2), among which NLRP3 inflammasome is the most studied. NLRP3 inflammasome is typically composed of NLRP3, ASC and pro-caspase-1. The activation of inflammasome involves both “classical” and “non-classical” pathways and the former pathway is better understood. The “classical” activation pathway of inflammasome is that the backbone protein is activated by endogenous/exogenous stimulation, leading to inflammasome assembly. After the formation of “classic” inflammasome, pro-caspase-1 could self-activate. Caspase-1 cleaves cytokine precursors into mature cytokines, which are secreted extracellularly. At present, the “non-classical” activation pathway of inflammasome has not formed a unified model for activation process. This article reviews the role of NLRP1, NLRP3, NLRC4, AIM2 inflammasome, Caspase-1, IL-1β, IL-18 and IL-33 in the fibrogenesis. Frontiers Media S.A. 2021-06-11 /pmc/articles/PMC8226128/ /pubmed/34177893 http://dx.doi.org/10.3389/fimmu.2021.643149 Text en Copyright © 2021 Zhang, Chen, Zhou, Wu and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Wen-Juan Chen, Shu-Juan Zhou, Shun-Chang Wu, Su-Zhen Wang, Hui Inflammasomes and Fibrosis |
title | Inflammasomes and Fibrosis |
title_full | Inflammasomes and Fibrosis |
title_fullStr | Inflammasomes and Fibrosis |
title_full_unstemmed | Inflammasomes and Fibrosis |
title_short | Inflammasomes and Fibrosis |
title_sort | inflammasomes and fibrosis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226128/ https://www.ncbi.nlm.nih.gov/pubmed/34177893 http://dx.doi.org/10.3389/fimmu.2021.643149 |
work_keys_str_mv | AT zhangwenjuan inflammasomesandfibrosis AT chenshujuan inflammasomesandfibrosis AT zhoushunchang inflammasomesandfibrosis AT wusuzhen inflammasomesandfibrosis AT wanghui inflammasomesandfibrosis |